VSEE HEALTH, INC. Files 8-K with Financials
Ticker: VSEEW · Form: 8-K · Filed: Oct 17, 2024 · CIK: 1864531
| Field | Detail |
|---|---|
| Company | Vsee Health, Inc. (VSEEW) |
| Form Type | 8-K |
| Filed Date | Oct 17, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-statements, exhibits, disclosure
TL;DR
VSEE HEALTH filed an 8-K with financials on Oct 16, 2024.
AI Summary
On October 16, 2024, VSEE HEALTH, INC. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating a routine disclosure of company information. No specific material events or transactions were detailed in the provided excerpt.
Why It Matters
This filing provides investors with updated financial information and exhibits, which are crucial for assessing the company's performance and making informed investment decisions.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report for financial statements and exhibits, not indicating any immediate material adverse events.
Key Players & Entities
- VSEE HEALTH, INC. (company) — Registrant
- October 16, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-41015 (company_id) — Commission File Number
- 86-2970927 (company_id) — I.R.S. Employer Identification No.
- 980 N Federal Hwy #304 Boca Raton, Florida 33432 (address) — Principal executive offices
- DIGITAL HEALTH ACQUISITION CORP. (company) — Former company name
- 20210526 (date) — Date of former company name change
FAQ
What is the primary purpose of this 8-K filing by VSEE HEALTH, INC.?
The primary purpose of this 8-K filing is to report financial statements and exhibits as of October 16, 2024.
What was VSEE HEALTH, INC.'s former company name?
VSEE HEALTH, INC.'s former company name was DIGITAL HEALTH ACQUISITION CORP.
When did the name change from DIGITAL HEALTH ACQUISITION CORP. to VSEE HEALTH, INC. occur?
The date of the name change was May 26, 2021 (20210526).
In which state is VSEE HEALTH, INC. incorporated?
VSEE HEALTH, INC. is incorporated in Delaware.
What is the Commission File Number for VSEE HEALTH, INC.?
The Commission File Number for VSEE HEALTH, INC. is 001-41015.
Filing Stats: 572 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2024-10-17 17:08:39
Key Financial Figures
- $0.0001 — on which registered Common Stock, $0.0001 par value per share VSEE The Nasdaq
- $11.50 — (1) share of common stock at a price of $11.50 per whole share VSEEW The Nasdaq St
Filing Documents
- tm2426433d1_8k.htm (8-K) — 29KB
- tm2426433d1_ex99-1.htm (EX-99.1) — 13KB
- 0001104659-24-109576.txt ( ) — 259KB
- vsee-20241016.xsd (EX-101.SCH) — 3KB
- vsee-20241016_def.xml (EX-101.DEF) — 26KB
- vsee-20241016_lab.xml (EX-101.LAB) — 36KB
- vsee-20241016_pre.xml (EX-101.PRE) — 25KB
- tm2426433d1_8k_htm.xml (XML) — 5KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On October 16, 2024, VSee Health, Inc. (the "Company") issued a press release announcing that the Company, in collaboration with the Kwajalein Atoll Local Government and Kwajalein Atoll Sustainability Laboratory, successfully demonstrated a groundbreaking telehealth initiative aimed at improving healthcare access for Marshallese veterans who served in the US military, and residents of the Kwajalein Atoll. A copy of the press release is furnished as Exhibit 99.1 hereto and incorporated herein by reference. The information included in this Item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K is not deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall this item and Exhibit 99.1 be incorporated by reference into the Company's filings under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such future filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits: Exhibit Description 99.1 Press Release, dated October 16, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. Dated: October 17, 2024 VSEE HEALTH, INC. By: /s/ Imoigele Aisiku Name: Imoigele Aisiku Title: Co-Chief Executive Officer